9th Annual Biomarkers Congress

Drug Design: Amgen

Total Score People Score Events Score
46 40 34
Date Event Presentation Speakers
May 19, 2010 Pre-Clinical / Clinical Development of Therapeutic Antibodies Translational Safety for Therapeutic Antibodies: Protecting Subjects and Enabling Risk:Benefit Decisions During Early Clinical Development Andrew Erdman
Targeting GPCRs with Therapeutic Antibodies Hai Yan
November 2, 2009 Track 4: Fourth Annual GPCR-based drug discovery Optimization and Mechanism of Action Studies of Allosteric Modulators of Calcium-Regulation Jeff Reagan
August 5, 2009 New Frontiers in Cancer Drug Development AMG 386, an Anti-Angiogenic Agent Targeting the Angiopoietin-Tie2 Pathway Jon Oliner
Biomarker Clinical Utility: How Can Qualification of a Biomarker's Clinical Utility Be Determined? Prospective or Retrospective or a Combination? Scott D Patterson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Ligands of Orphan GPCRs Identified from Inducible Expression of the Receptors and Cell-based Reporter Screen Paul Lee
August 3, 2009 The Next Wave of Antibody Therapeutics Pharmacodynamic Biomarkers of Antibodies Frank Calzone
Combinatorial Strategies for Tumor Inhibition using AMG 479, a Fully Human Monoclonal Antibody that Inhibits the Insulin-like Growth Factor (I) Receptor (IGF-1R) Frank Calzone
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety Translating Metabolomic Data into Mechanistic Understanding and Action: A Case Study Jeffrey W. Lawrence
June 9, 2009 RNAi for Target Identification and Validation A Framework for the Analysis of RNAi Phenotypes as Quantitative Traits Kim Quon
June 9, 2009 Cell and Tissue-Based Assays for HTS Killing One Bird with Two Stones - A Platform for Testing Putative Anti-Cancer Agents in Combination using Cell-Based Assays Sharon Zhao
June 8, 2009 RNAi for Functional Screens OPTIMIZING RNAi DELIVERY FOR IN VITRO APPLICATIONS Paul D. Kassner
May 11, 2009 Patient Recruitment in Clinical Trials KEYNOTE: Increasing Investigator Site Performance & Productivity Brian York
Opening Remarks Brian York
March 9, 2009 Drug Development Latin America NFORMAL BREAK-OUT ROUNDTABLES Fidela Li Moreno
February 9, 2009 Immunogenicity for Biologics 2009 Methodology for immunogenicity assessment Steve Swanson
Incurred sample reanalysis – Amgen’s experiences Mark Ma
January 26, 2009 Pre-Conference Short Course* Jean W Lee
January 26, 2009 Biomarker Assay Development Quantification of “Total” and/or “Free” Target Protein Biomarker: Approaches and Applications Jean W Lee
January 26, 2009 Translational Cancer Medicine Pre-Conference Short Course* : Fit-for-Purpose Biomarker Assay Development and Validation Jean W Lee
VECTIBIX : The KRAS Signaling Pathway Biomarker in Oncology: From Prognostic to Predictive Scott D Patterson
January 26, 2009 7th Annual Partnering with Central Labs B2 : Archival Surgical Pathology Specimens: A New Exercise in Clinical Trials Carol W Johnson
Risk Assessment : Current and Future Metrics Champion Consortium Metrics Initiatives Sue Hwang
PANEL DISCUSSION : Comparing Approaches: Preferred Providers vs Competitive Bidding, What is your Best Choice? Roberto Vaccaro
Track A : Overview of Metrics: Definition Refinement & Update from the Central Lab MCC Initiative Sue Hwang
January 5, 2009 High Content Analysis Use of the ImageStream Imaging Flow Cytometer Platform to Investigate the Role of PI3K in Whole Blood Phagocytosis of GFP-labeled E.coli Gary Elliott
November 26, 2008 4th Annual Audits and Inspections for Clinical Trials and Pharmacovigilance An extensively experienced guide to MHRA sponsor and site inspections, including a comparison to FDA site inspections in Europe Paul Strickland,
November 17, 2008 BIO-Europe 2008 A Day in the Life of Experienced Dealmakers – Year 6! Andrew Gengos
A Day in the Life of Experienced Dealmakers – Year 6! Andrew Gengos
November 5, 2008 DIA's 6th Canadian Annual Meeting: Benefit and Risk Management: An Evolution in Progress THE PERSPECTIVE OF THE PHARMACEUTICAL INDUSTRY Karen , Burke
TRACK 3 : AN INNOVATOR’S PERSPECTIVES ON SEB ISSUES Andrew Fox
TRACK 3 : QBD APPLIED TO BIOLOGICS Jennifer Mercer
October 20, 2008 Protein Expression Europe Epitope Mapping with Saturation Mutagenesis: A Case-Study of Single-Chain, Conformation-Sensitive Antibodies to the Erythropoietin Receptor Christopher Mehlin
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics An Overview of the Bioanalysis of Protein Therapeutics Binodh DeSilva
Clinical Assessment of Neutralizing Antibodies to Protein Therapeutics Michele S. Swanson
Successful Development of Biotherapeutics: Scientific and Regulatory Strategies and Hurdles for Toxicology and ADME/PK Paul Pearson
Toxicology Study Strategies for Biopharmaceuticals in Comparison to Small Molecules Mary Ellen Cosenza
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Panelists Frank Calzone
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Conducting Clinical Trials in China Shaoyu Chen
March 25, 2008 Preclinical Development Imaging Biomarkers in Early Clinical Development of Novel Therapeutic Agents Jeffrey Evelhoch
March 25, 2008 TRANSLATIONAL MEDICINE Imaging Biomarkers in Early Clinical Development of Novel Therapeutic Agents Jeffrey Evelhoch
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic In Vivo Imaging in Early Drug Development Jeffrey Evelhoch
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Design and Synthesis of Calcitonin-Gene Related Peptide (CGRP) Antagonists Jerry "Ryan" Holder
January 21, 2008 Pre-Filled Syringes ADVANCES IN MATERIALS, COMPONENTS AND DEVICES AND ITS IMPACT ON PRODUCT STABILITY Thomas Schoenknecht
Chairman's Opening Remarks Thomas Schoenknecht
Chairman's Opening Remarks Thomas Schoenknecht
December 10, 2007 Dissolution Testing IMPLEMENTING USP APPARATUS 4 FLOW THROUGH DISSOLUTION TESTING FOR POORLY SOLUBLE COMPOUNDS Jian (Jan) B. Fang
November 28, 2007 Second Annual Portfolio Management: Creating a Portfolio for Optimal Productivity Nov (28-29) Assessing Drug Development Risk to Enable Gated Resource Allocation, Life-cycle and Portfolio Decision-Making (14:00-14:40) Rajendra Mohabir
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) CONTRIBUTION OF ACADEMIC INSTITUTES (13:30-15:00) Erich Wohlhieter
CONTRIBUTION OF ACADEMIC INSTITUTES: INTERACTIVE PANEL Supply Chain Challenges and Solutions to Reduce Cycle Time (14:20-15:00) Erich Wohlhieter
CLINICAL DEVELOPMENT AND OPERATIONS (09:10-14:45) Mamata Gokhale
CLINICAL DEVELOPMENT AND OPERATIONS: INTERACTIVE PANEL:Outsourcing Globally and Executing International Trials in India (14:00-14:45) Mamata Gokhale
CLINICAL DEVELOPMENT AND OPERATIONS: Strategic Planning for Clinical Development Operations in India: Short and Long Term Barriers to Overcome (11:15-11:45) Mamata Gokhale
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) CASE STUDIES OF PRACTICAL SYNTHESIS (13:30-18:30) Oliver Thiel
CASE STUDIES OF PRACTICAL SYNTHESIS: Practical Synthesis of TRPV1 Antagonists for Treatment of Pain (14:10-14:40) Oliver Thiel
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Jean W Lee
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.